Investigators → Priya N. Subramanian
ORA-FOREIGN-IND · Office of Global Operations (Foreign Drug & API Cadre)
Strictness Percentile: 81th
Priya N. Subramanian — FDA Investigator Citation Profile
Focuses heavily on 21 CFR 211.67(a) and 21 CFR 211.192. Expect a request for your Approved Supplier List, raw component identity testing chromatograms, and last 24 months of OOS/CAPA logs within the first 2 hours of opening conference.
Top Cited Clauses: 21 CFR 211.67(a), 21 CFR 211.192, 21 CFR 11.10
Simulate Inspection by Priya N. Subramanian →
Recent Form 483s Linked to Priya N. Subramanian
OPS International Inc dba Olympia Pharmaceuticals (2026-09-03) · 2 observations
View 483 →CD Pharmacy LLC dba Red Rock Pharmacy (2026-07-31) · 2 observations
View 483 →Lt Col Luke Weather Jr Veterans Affairs Medical Center (2026-06-04) · 2 observations
View 483 →Fresenius Kabi USA, LLC (2026-05-14) · 2 observations
View 483 →QuVa Pharma Inc (2026-05-04) · 2 observations
View 483 →Cliantha Research Limited (2026-04-17) · 2 observations
View 483 →Fujifilm Diosynth Biotechnologies USA Inc. (2026-03-27) · 2 observations
View 483 →Fougera Pharmaceuticals, LLC. (2026-03-26) · 2 observations
View 483 →SGS North America Inc. (2026-03-20) · 2 observations
View 483 →BioLife Plasma Services L.P. (2026-03-20) · 2 observations
View 483 →Atlantic Analytical Laboratories LLC (2026-03-17) · 2 observations
View 483 →Corixa Corporation (2026-03-12) · 2 observations
View 483 →PETNET Solutions, Inc. (2026-03-06) · 2 observations
View 483 →Farmina Pet Food USA LLC (2026-03-05) · 2 observations
View 483 →Eugia Pharma Specialities Limited (2026-02-27) · 2 observations
View 483 →